52479-85-3 Usage
Description
Exifone is a nootropic indicated for the treatment of cognitive dysfunctions in geriatric
patients. Its reported clinical efficacy is ascribed to pharmacological activities including
activation of neuronal oxygen and glucose metabolism, free radical scavenging, and
indirect effects on serotonergic and dopaminergic pathways.
Chemical Properties
yellow amorphous powder
Originator
Pharmascience (France)
Uses
Exifone is a nootropic drug and cognitive enhancing agent. Exifone is a free radical scavenger shown to have protective effects againts Exifone has been shown to antagonize amnesias induced by benzodiazepines in mice.
Preparation
Preparation by condensation of gallic acid with pyrogallol, ? in the presence of zinc chloride at 120° (good yield) or at 145° for 3 h (Nencki reaction); ? in the presence of zinc chloride and phosphorous oxychloride at 80° for 2 h, via Fries rearrangement.
Brand name
Adlone
Check Digit Verification of cas no
The CAS Registry Mumber 52479-85-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,4,7 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 52479-85:
(7*5)+(6*2)+(5*4)+(4*7)+(3*9)+(2*8)+(1*5)=143
143 % 10 = 3
So 52479-85-3 is a valid CAS Registry Number.
52479-85-3Relevant articles and documents
Evaluation of polyhydroxybenzophenones as α-glucosidase inhibitors
Hu, Xuesen,Xiao, Yang,Wu, Jianlong,Ma, Lin
experimental part, p. 71 - 77 (2011/09/21)
This experiment was designed to synthesize 18 kinds of polyhydroxybenzophenones by using Friedel-Crafts reaction, and to measure the inhibitory activity on α-glucosidase with p-nitrophenyl-β-D- galactopyranoside (PNPG) as a substrate. Here, acarbose (IC50a= a1674.75aaμmolaL-1) was used as the reference inhibitor. The results demonstrated that most of the target compounds had remarkable inhibitory activities on α-glucosidase. Among all these compounds, 2,4,4′,6-butahydroxydiphenylketone (11) was found to be the most potent α-glucosidase inhibitor with an IC50 value of 10.62aaμmolaL-1. In addition, we found these compounds were competitive inhibitors through the kinetic analysis. The results suggested that such compounds might be utilized for the development of new candidates for diabetes treatment. A series of polyhydroxybenzophenones was synthesized and evaluated as α-glucosidase inhibitors. Compound 11 was found to be the most potent inhibitor. Copyright